Vertex Pharmaceuticals (VRTX) Misses Q1 Earnings and Revenue Estimates [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
This compares to earnings of $4.76 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -3.79%. A quarter ago, it was expected that this drugmaker would post earnings of $3.99 per share when it actually produced earnings of $3.98, delivering a surprise of -0.25%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Vertex , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $2.77 billion for the quarter ended March 2025, missing the Zacks Consensus Estimate by 1.72%. This compares to year-ago revenues of $2.69 billion. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Vertex shares have ad
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target raised by analysts at Leerink Partners from $456.00 to $525.00. They now have an "outperform" rating on the stock.MarketBeat
- Should You Be Confident in Vertex Pharmaceuticals Incorporated's (VRTX) Long-Term Outlook? [Yahoo! Finance]Yahoo! Finance
- Forget Moderna Stock, This is a Much Better Buy [Yahoo! Finance]Yahoo! Finance
- Why a 63% Vertex Selloff Didn't Scare Off a New $13 Million Investor [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals (VRTX): Valuation Check After Positive CASGEVY Pediatric Data and Kidney Disease Breakthrough Progress [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 11/3/25 - Beat
VRTX
Sec Filings
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- VRTX's page on the SEC website